Chandra Bhagat Pharma Ltd (NSE: CBPL), ISIN INE07QQ01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CBPL last traded at ₹34.40 (+3.55%), with a 52-week range of ₹29.70 to ₹59.00 (as of 30 Jul 2026).
Shareholding as of Sep 2025: promoters 72.19%, FIIs 0.61%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.